The digital subscription version of the Exercise-Induced Bronchoconstriction (ATS) GUIDELINES Pocket Guide contains all the same great information found in the physical pocket guide, and can be accessed on mobile devices and online:
Price: $4.99 per year
Subscribe to additional guideline titles for discounted rates
Includes automatic updates during the term of your subscription
CPT® and ICD10 codes can be added to certain guidelines for an additional fee
Supported platforms
iPhone and iPad
Android phones and tablets
Online (internet connection required)
Content on the Guideline Central mobile app accessible without an internet connection
Access to additional guideline summaries, clinical calculators, and more
For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.
For individual use only; contact us for group and site licenses.
The Exercise-Induced Bronchoconstriction GUIDELINES Pocket Guide is endorsed by the American Thoracic Society and is based on the latest published guidelines. This practical quick-reference tool contains Diagnostic criteria, graded recommendations for treatment, a diagnostic and treatment algorithm and complete drug tables.
Multifold
80# Diamond Silk Cover with Satin Aqueous Coating
4.25″ x 7.25″
Key Points
Diagnosis
Treatment
Figures
Diagnostic and Treatment Algorithm
First-line Medications
Second-line Medications
Inhaled Corticosteroids
The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 15,000 members. In this introductory section, you will find information about the people and programs that make the ATS the world's leading medical association dedicated to advancing our clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.
Exercise-induced bronchoconstriction (EIB) describes acute airway narrowing that occurs as a result of exercise. EIB occurs in a substantial proportion of patients with asthma but may also occur in individuals without known asthma.
Diagnosis
The diagnosis of EIB is established by changes in lung function provoked by exercise, not on the basis of symptoms.
Serial lung function measurements after a specific exercise or hyperpnea challenge are used to determine if EIB is present and to quantify the severity of the disorder. It is preferable to assess FEV1, because this measurement has better repeatability and is more discriminating than peak expiratory flow rate.
The airway response is expressed as the percent fall in FEV1 from the baseline value. The difference between the pre-exercise FEV1 value and the lowest FEV1 value recorded within 30 minutes after exercise is expressed as a percentage of the pre-exercise value. The criterion for the percent fall in FEV1 used to diagnose EIB is ≥10%.
The severity of EIB can be graded as follows:
Percent fall in FEV1 from the pre-exercise level
Severity
10%-24%
Mild
25%-49%
Moderate
≥50%
Severe
A number of surrogates for exercise testing have been developed that may be easier to implement than exercise challenge. These surrogates include eucapnic voluntary hyperpnea or hyperventilation, hyperosmolar aerosols, including 4.5% saline, and dry powder mannitol.
Want to save this for later? And your free sample to your Library.
Add to Library
Related Pocketcards
To get started, log in or create your free account Create Account
Our Commitment to Our Customer’s Privacy
Thank you for being a user of Guideline Central!
As part of our continued efforts towards protecting your privacy and personal information, we’ve made recent updates to our privacy policy.
By updating our privacy policy with clearer language, our goal is to help you better understand what data we collect and how we use that information.
When we collect your data through site visits and account creation, we agree to never sell that information to third-parties.
This personal information is used solely to provide you a more personalized experience when using the Guideline Central website and app.
At any time, you may opt out of tracking or request account deletion.
Please visit our privacy policy page for more information.
